Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000484457 | SCV000572516 | uncertain significance | not provided | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant is denoted RAD51C c.966-3C>T or IVS7-3C>T and consists of a C>T nucleotide substitution at the -3 position of intron 7 of the RAD51C gene. In-silico analysis, which includes splice predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. RAD51C c.966-3C>T was not observed in large population cohorts (Lek 2016). Based on currently available information, it is unclear whether RAD51C c.966-3C>T is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Labcorp Genetics |
RCV000576273 | SCV000676966 | uncertain significance | Fanconi anemia complementation group O | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the RAD51C gene. It does not directly change the encoded amino acid sequence of the RAD51C protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RAD51C-related conditions. ClinVar contains an entry for this variant (Variation ID: 422917). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with inconclusive levels of altered splicing (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Color Diagnostics, |
RCV000775948 | SCV000910452 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-12-03 | criteria provided, single submitter | clinical testing |